Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology

NCT01551342 is registered in ClinicalTrials.gov with Zetiq Technologies as lead sponsor.

NCT NCT01551342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01551342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology
Lead sponsor
Zetiq Technologies
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
Not reported
Enrollment
500 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer transitional cell carcinoma